Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion type Assertion NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_head.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion description "[These findings suggest that the upregulation of SPARC mRNA expression is an early event in the development and progression of BE and EA, and that high SPARC expression may be a clinically useful biomarker for the detection of occult adenocarcinoma, and that a widespread 'field effect' is present in the NE of patients with oesophageal adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_provenance.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion evidence source_evidence_literature NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_provenance.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion SIO_000772 14562024 NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_provenance.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion wasDerivedFrom befree-2016 NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_provenance.
- NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_assertion wasGeneratedBy ECO_0000203 NP417077.RAI2Ay3CqKOT9jhb0i_mYu-ppwCNXFOLy3hKTufiNBBVY130_provenance.